The Effectiveness of Hybrid Nutritional Guidance for Pregnant Women with Glucose Metabolic Disorders

The Effectiveness of Hybrid Nutritional Guidance for Pregnant Women with Glucose Metabolic Disorders - The Effectiveness of Hybrid Nutritional Guidance for Pregnant Women with Glucose Metabolic Disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044625

Enrollment

Registered

2021-07-05

Start date

2021-07-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant woman with glucose metabolic disorder

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women with abnormal glucose metabolism, GDM and pregnant women with diabetes, were treated at the Kitasato University Hospital during this study period.

Exclusion criteria

Exclusion criteria: (1) Blind patients (2) Patients with other implantable medical devices (pacemakers, etc.) (3) Patients using an insulin pump (4) Patients who are not eligible judged by this study investigators

Design outcomes

Primary

Measure	Time frame
Changes in sensor glucose levels during the first, second, and third trimesters of pregnancy n pregnant women with glucose metabolic disorder.	—

Secondary

Measure	Time frame
(1) Changes in hemoglobin A1c and glycated albumin during the pregnant period. (2) Changes in body weight during the pregnant period. (3) Changes in dietary compliance during the pregnant period. (4) Changes in Problem Area in Diabetes Survey (PAID), Diabetes Treatment Satisfaction Questionnaire (DTSQ), and Diabetes Diet-related Quality of Life Scale. (5) Perinatal outcomes and adverse events, including skin disorders, associated with the use of Libre	—

Measure

Time frame

(1) Changes in hemoglobin A1c and glycated albumin during the pregnant period. (2) Changes in body weight during the pregnant period. (3) Changes in dietary compliance during the pregnant period. (4) Changes in Problem Area in Diabetes Survey (PAID), Diabetes Treatment Satisfaction Questionnaire (DTSQ), and Diabetes Diet-related Quality of Life Scale. (5) Perinatal outcomes and adverse events, including skin disorders, associated with the use of Libre

—

Countries

Japan

Contacts

Public ContactAkinori Hayashi

Kitasato University School of Medicine Endocrinology, Diabetes and Metabolism

ahayashi@kitasato-u.ac.jp0427788111

Outcome results